4th Quarter - Report

FORBES-TATE for ADAPT PHARMA INC.

Firm
Client
Income
$100,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 LHHS Appropriations (H.R. 6470, S.3158, H.R. 6157 Labor/HHS/Education Appropriations Act of 2019, and Continuing Appropriations Act, 2019); Issues related to CDC; Issues related to HHS; Issues related to DOJ; Issues related to funding for community-based nalaxone; Issues related to ONDCP funding.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
ELIZABETH GREER —
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 6157 (115th), H.R. 6470 (115th), S. 3158 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.